Katherine Giannamore
    • Labeling & Claims
    • Label & Marketing Reviews
    • Ingredient Reviews
    • Supplement Facts Panels
    • Outer Packaging Requirements
    • Website Reviews
    • Nutrient Content Claims
    • Organic & Natural Claims
    • Structure/Function Claims
    • Disease Claims
    • Health Claims
    • Food, Supplements & Devices
    • FDA Food Services
    • Dietary Supplement Services
    • 30-Day Notification (NDI)
    • 510(k) / Premarket Clearance
    • Premarket Approval (PMA)
    • Imports, Enforcement & General Counsel
    • FDA Imports
    • Warning Letter Responses
    • FDA Consultant Services
  • About
  • Food & Drug Blog
  • Contact
(866) 785-0873 Schedule a Consultation

Food & Drug Blog

More Recalls of Pet Food in Wake of Salmonella Detection

FDA, Pet Food, Pet foods, Recalls, SalmonellaFDA

The U.S. Food and Drug Administration (“FDA”) has announced the recall of additional pet food due to the detection of Salmonella. According to the FDA, WellPet LLC initiated the voluntary recall as a result of the bacteria being found in …

Read More

FDA Explains its Regulation of Bottled Water

Beverages, Bottled Water, CGMP, FDA, LabelingFDA

Recently, the U.S. Food and Drug Administration (“FDA”) published “Food Facts”, a document providing the public with information concerning the Agency’s regulation of bottled water. Found here, the document details how the Agency works in conjunction with the Environmental Protection …

Read More

FDA Approves New Orphan Drug (Elelyso) to Treat Gaucher Disease

Drugs, FDA, Gaucher disease, Orphan Designation, Orphan DrugFDA

On May 1, 2012, the U.S. Food and Drug Administration (“FDA”) approved a new orphan drug to treat Gaucher disease. The drug, Elelyso (taliglucerase alfa), is an injection therapy used for enzyme replacement in people with the rare genetic disorder. …

Read More

FDA Approves Drug for Treatment of Plague Through Animal Efficacy Rule

Animal Efficacy, Drugs, FDA, Labeling, NDAFDA

On April 27, 2012, the U.S. Food and Drug Administration (“FDA”) approved Levaquin (levofloxacin), a drug used to treat those afflicted with plague. In addition to treating those with the deadly infection, Levaquin is also approved to reduce the risk …

Read More

FDA Warns Companies Marketing Supplements Containing DMAA

Dietary Supplements, Enforcement, FDA, NDI, Supplements, Warning LettersFDA

On April 27, 2012, the U.S. Food and Drug Administration (“FDA”) issued warning letters to several dietary supplement manufacturers in connection with their alleged improper marketing of supplements containing dimethylamylamine (“DMAA”). DMAA, also referred to as geranium extract, is an …

Read More

FDA Approves Vivus Inc.’s Stendra to Treat Erectile Dysfunction

Drugs, Erectile Dysfunction, FDA, NDAFDA

On April 27, 2012, the U.S. Food and Drug Administration (“FDA”) approved the drug Stendra (avanafil), a drug used to treat erectile dysfunction (“ED”). Marketed by Vivus, Inc., Stendra is intended to be taken by men on an as-needed basis …

Read More

FDA Issues Statement on USDA BSE (“mad-cow”) Case

FDA, mad cow, USDAFDA, USDA

On April 26, 2012, the U.S. Food and Drug Administration (“FDA”) issued a statement concerning the recent announcement confirming a case of bovine spongiform encephalopathy (“BSE”). The U.S. Department of Agriculture’s (“USDA”) announcement confirming and explaining this case may be …

Read More

FDA Publishes Global Engagement Report, Highlighting Efforts Abroad

Drugs, FDA, Food, imports, Medical DevicesFDA

On April 23, 2012, the U.S. Food and Drug Administration (“FDA”) released its “Global Engagement Report,” a document detailing the various strategies undertaken by the agency to ensure that FDA-regulated products, including foods, medical devices, drugs, etc., are manufactured under …

Read More

FDA Enters into Consent Decree with Seafood Processor over Alleged Manufacturing Deficiencies

Enforcement, FDA, Listeria, Seafood, Warning LettersFDA

On April 11, 2012, the U.S. Food and Drug Administration (“FDA”) announced that, with the aid of the Department of Justice, it has entered into a consent decree with a California seafood processor. The consent decree precludes the company from …

Read More

FDA Warns Consumers of Dangers Associated with Crackers Lacking Proper Allergy Warnings

Allergens, Crackers, Food, LabelingFDA

On April 5, 2012, the U.S. Food and Drug Administration (“FDA”) issued a press release warning consumers not to eat certain crackers because of the potential dangers for those with milk or nut allergies. TWI Foods Inc., the crackers’ manufacturer …

Read More

Posts pagination

< Page 1 … Page 13 Page 14 Page 15 >


    Katherine L. Giannamore
    Rated by Super Lawyers


    loading ...
    Shehadeh Giannamore, PLLC

    Toll-free: (866) 785-0873
    Direct: (305) 507-9843
    Email: contact@giannamore-law.com

    Reachable seven days a week · Response within 24 hours

    Practice Areas

    • Food & Beverage
    • Dietary Supplements
    • Cosmetics & Labeling
    • Medical Devices
    • Drugs & OTC
    • Enforcement & Import Defense

    Popular Services

    • FDA Label Reviews
    • Ingredient Reviews
    • FDA Imports
    • Warning Letter Responses
    • 30-Day NDI Notification

    Firm

    • About
    • Food & Drug Blog
    • Contact
    • Google Reviews

    Information shared on this website and blog is for informational purposes only and may not provide the most up-to-date legal and regulatory information, as we do not provide updates to individual articles after publication. Any commentary or legal analysis herein is for general informational purposes and not to be relied upon for individual legal advice and does not establish an attorney-client relationship.

    © 2026 Shehadeh Giannamore, PLLC. All rights reserved.